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Jin Tang, Leye He, Zhi Long and Jingchao Wei*Abstract: The current report presents the case of a 42-year-old male with extraordinarily salient urination difficulty
that had lasted 6 months. Transrectal ultrasonography and pelvic magnetic resonance imaging demonstrated
prostatic hyperplasia and cyst. PSA level was 20.65 (>4) μg/L in the patient. Transrectal prostatic biopsy revealed
benign prostatic hyperplasia. He agreed to receive plasmakinetic resection of the prostate. During operation a
lobulated lump was unexpectedly found on the verumontanum, with the prostate macroscopically normal. Complete
tumor excision was performed and pathological assessment indicated phyllodes tumor of the verumontanum. The
patient had an uneventful post-operative course and recovered well. The diagnosis, histological classification, treatment,
and prognosis of this case are presented. It is necessary to perform cystoscopy to exclude verumontanum tumor even
when all imaging examinations indicate prostate hyperplasia, especially in young males.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
1868931661161758
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The incidence of verumontanum tumor is low. Several
phyllodes tumors of the seminal vesicle and prostate
have been reported; however, studies describing phyl-
lodes tumor of the verumontanum are scarce.
Phyllodes tumor is defined as a neoplasm with a foli-
ated structure composed of cellular stroma and benign
epithelial elements. Most phyllodes tumors occur in the
breast [1]. Here, a patient with a phyllodes tumor of the
verumontanum is reported, and the histological classifica-
tion, treatment, and prognosis of the tumor are discussed.Case presentation
In December 2014, a 42-year-old male presented to the
Department of Urology, The Third Xiangya Hospital of
Central South University (Changsha, China) with a six-
month history of dysuria and urgent urination. He did
not report frequent urination or gross hematuria. Digital
Rectal Examination revealed a hard nodule in the right
posterior part of the prostate. No other anomaly was ob-
served after physical examination. The maximum urine
flow rate was 6 ml/s, and urodynamic examination* Correspondence: tangjinboy@163.com
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creativecommons.org/publicdomain/zero/1.0/indicated bladder outlet obstruction. The patient had no
significant medical history. Serum prostate-specific antigen
(PSA) levels were 21 ng/mL. Transrectal ultrasonography
disclosed a serious possibility of prostatic hyperplasia and
cyst. Pelvic magnetic resonance imaging revealed a hyper-
plastic nodule with cystic changes and a clear boundary
Figs. 1 and 2. An 8-core transrectal ultrasound-guided
prostate biopsy was performed. Histopathology revealed
benign prostatic hyperplasia. The patient agreed to
undergo plasmakinetic resection of the prostate. During
the surgey a lobulated lump with intact external surface
was unexpectedly found on the verumontanum, to which
it was connected by pedicle. The lump constituted a valve
for posterior urethra, resulting in bladder outlet obstruc-
tion and difficult urination Figs. 3 and 4. There was no
obvious hyperplasia of the prostate. Complete lump exci-
sion was then performed and pathological assessments re-
vealed phyllodes tumor of the verumontanum. The lump
surface was coated with transitional epithelium, and a sig-
nificant hyperplasia of fibers and fibroblasts in its mesen-
chyme was observed. Scattered myxoid degeneration was
also found Figs. 5 and 6. The expression of Ki-67 was
evaluated by immunohistochemical staining, and a Ki-67
proliferation index of about 12 % was obtained (Fig. 7).
The patient had an uneventful post-operative course andcle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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Fig. 1 MRI—Transverse section. T2 weighted phase. Multiple
nodules of long T2 signal are visible in the right area of the prostate
Fig. 3 Intraoperative view. A papillary lobulated lump with intact
surface was found during the operation, acting as a valve for the
bladder outlet
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the operation was 23 mL/s.
Discussion
To our knowledge, no previous reports of verumonta-
num phyllodes tumor have been published. This may be
the first case of phyllodes tumor of the verumontanum.
Previously reported phyllodes tumors are mostly located
in the female breast tissue, followed by the prostate [2].
Less than 15 and 100 cases of phyllodes tumors of the
seminal vesicle and prostate, respectively, have been re-
ported to date. Verumontanum tumors are rare, with ex-
tremely atypical symptoms. Phyllodes tumors are rare
even in the breast, where they account for less than 1 %
of all neoplasms [1]. Ferrariet et al. proposed that phyl-
lodes tumor of the prostate is a potential diagnosis for
previously healthy young men with hydronephrosis and
lower urinary tract symptoms [3]. The patient described
here presented with salient difficult urination. Intraoper-
ative observation revealed overt hyperplasia of the blad-
der’s trabecula and diverticulum. Image assessment also
indicated prostatic hyperplasia.
The concept of phyllodes tumor was initially used for
breast tissues. In 1982, the World Health Organization
(WHO) declared the term “phyllodes tumor” to be the
most appropriate among more than 60 synonyms ofFig. 2 MRI—Sagittal section. T2 weighted phase. Bump of posterior
urethral extruding to the bladderbreast neoplasms [4]. Compared to breast adenocarcin-
oma, phyllodes tumors tend to affect younger individuals
[5]. The majority of phyllodes tumors of the breast have
infiltrative margins. Phyllodes tumors are epithelial stro-
mal tumors, with the unique feature of being a blend of
stromal and epithelial tissues; the presence of both epi-
thelial and stromal elements is necessary to confirm the
diagnosis [2]. The misdiagnosis rate of breast phyllodes
tumors is relatively high, since they are histologically
similar to fibroadenoma. It is important to differentiate
phyllodes tumors from other benign breast tumors [1].
The accepted histological classification of phyllodes tu-
mors in the breast is to divide masses into benign, bor-
derline, and malignant subtypes according to features
such as tumor margins (pushing or infiltrative), stromalFig. 4 Intraoperative view. The lump was connected to the
verumontanum by a pedicle
Fig. 5 Microscopic assessment of the tumor revealed an epithelial-
stromal tumor, including irregular-shaped benign glandular elements
and excessive hyperplasia of stromal tumor cells. Stromal cells
exhibit pleomorphism, and were multinucleated and giant
(hematoxylin and eosin; original magnification × 200)
Fig. 7 A total of 500 cells were counted at the most intense Ki-67-
stained area for the assessment of Ki-67 positivity(100 ×magnification)
Tang et al. Diagnostic Pathology  (2015) 10:69 Page 3 of 4overgrowth, tumor necrosis, cellular atypia, and the
number of mitotic cells per high power field [2, 4, 6]. No
cases of phyllodes tumor of the verumontanum have
been reported, and it is difficult to develop any definitive
criteria for its grading. In the patient described here, an
estimated Ki-67 proliferation index of 12 % was ob-
tained. This finding indicated that tumor cell prolifera-
tion was not active, developing relatively slowly. In the
mammary gland, the presence of high cellularity and mi-
totic activity correlates with tumors of malignant and
metastasizing potential [7].
Few reliable clinical and histological prognostic factors
of phyllodes tumors have been identified. Fain JS et al.
reported the first case of high-grade phyllodes tumor of
the seminal vesicle, with a lung metastasis four years
after cystoprostatoseminovesiculectomy. They proposedFig. 6 An irregular cleft like space is lined by epithelium and
invested with cellular stroma (H & E, original magnification × 200)that like breast and prostate tumors, phyllodes tumors
of the seminal vesicle should be considered high-grade
lesions (malignant) with significant mitotic activity, stro-
mal pleomorphism, and stromal overgrowth [8]. Abe
et al. reported a patient suffering from cystosarcoma
phyllodes of the seminal vesicle who died 11 months
after tumor removal by open operation [9]. The selection
of the initial surgical approach is of great importance for
phyllodes tumors of the breast. Either wide excision or
mastectomy is recommended for breast phyllodes tu-
mors, provided histologically clear specimen margins are
ensured [1]. Complete surgical resection offers high rates
of local control and disease-free survival [4]. However, in
rare cases where metastasis occurs, prognosis tends to
be poor [5]. Complete excision of the tumor is appropri-
ate for its intact surface, and the patient described here
had a quick recovery.
Conclusion
A rare case of phyllodes tumor of the verumontanum was
described in this report. This neoplasm had similar symp-
toms with prostatic hyperplasia, and was misdiagnosed be-
fore surgery. For young males, posterior urethral tumors
are potential diagnoses when they present with salient
symptoms of bladder outlet obstruction. Phyllodes tumor
of the verumontanum, as seen with this case, has possible
local proliferative activity without metastatic potential,
and transurethral resection may be required. Close period-
ical follow-up is essential, as progression requiring more
aggressive surgical intervention can be observed.
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